COVID-19 Coronavirus Research Tools Publications

View selected publications citing GeneCopoeia’s COVID-19 research products from the recent literature

2023

Yoshizue, T., et al. (2023). Antisera Produced Using an E. coli-Expressed SARS-CoV-2 RBD and Complemented with a Minimal Dose of Mammalian-Cell-Expressed S1 Subunit of the Spike Protein Exhibits Improved Neutralization. Int J Mol Sci doi: 10.3390/ijms241310583 [Lenti-Pac™ SARS-CoV-2 Truncated Spike protein-pseudotyped (D614G) Lentivirus Packaging Kit]
Passariello, M., et al. (2023). Comparative Analysis of a Human Neutralizing mAb Specific for SARS-CoV-2 Spike-RBD with Cilgavimab and Tixagevimab for the Efficacy on the Omicron Variant in Neutralizing and Detection Assays. Int J Mol Sci doi: 10.3390/ijms241210053 [Lenti-Pac™ SARS-CoV-2 Truncated Spike protein-pseudotyped (D614G) Lentivirus Packaging Kit]
Zhang, Y., et al. (2023). Extracellular Vesicles Expressing CD19 Antigen Improve Expansion and Efficacy of CD19-Targeted CAR-T Cells. Int J Nanomedicine doi: 10.2147/IJN.S390720 [lentiviral vector pCDH-CMV-CD19]

2022

Seenappa, L.M., et al. (2022). Amphiphile-CpG vaccination induces potent lymph node activation and COVID-19 immunity in mice and non-human primates. NPJ Vaccines doi: 10.1038/s41541-022-00560-3 [Lentifect™ SARS-CoV2 Spike-pseudotyped Lentiviral particles]
Sun, P.F., et al. (2022). Asymptomatic or symptomatic SARS-CoV-2 infection plus vaccination confers increased adaptive immunity to variants of concern. iScience doi: 10.1016/j.isci.2022.105202 [HEK293-ACE2 expressing cell lines]
Suzuki, Y., et al. (2022). Design and lyophilization of lipid nanoparticles for mRNA vaccine and its robust immune response in mice and nonhuman primates. Mol Ther Nucleic Acids doi: 10.1016/j.omtn.2022.09.017 [ACE2 and TMPRSS2-expressing HEK293T cells]
Fernandes, M.F., et al. (2022). Effect of cannabidiol on apoptosis and cellular interferon and interferon-stimulated gene1 responses to the SARS-CoV-2 genes ORF8, ORF10 and M protein. bioRxiv doi: 10.1101/2022.01.11.475901 [OMICSLINK™ SARS-CoV-2 ORF8, ORF10, and M ORF expression clones]
Hwang, J-Y., et al. (2022). Humoral and Cellular Responses to COVID-19 Vaccines in SARS-CoV-2 Infection-Naïve and -Recovered Korean Individuals. Vaccines doi: 10.3390/vaccines10020332 [ACE2-expressing HEK293T stable cell line]
Dai, H., et al. (2022). Rapid differentiation of SARS-CoV-2 variants on a nanotechnology enhanced DNA-chip. Reseearch Square doi: 10.21203/rs.3.rs-1641024/v1 [SARS-CoV-2 Spike-pseudotyped lentiviral particles]
Zhang, L., et al. (2022). Recombinant ACE2 protein protects against acute lung injury induced by SARS-CoV-2 spike RBD protein. Critical Care doi: 10.1186/s13054-022-04034-9 [OMICSLINK™ ACE2, SARS-CoV-2 Spike ORF expression clones]
Park, H., et al. (2022). TMED3 Complex Mediates ER Stress-Associated Secretionof CFTR, Pendrin, and SARS-CoV-2 Spike. Advanced Science doi: 10.1002/advs.202105320 [ACE2- and TMPRSS2-expressing HEK293T stable cell line]
Sim, J-R., et al. (2022). Amelioration of SARS-CoV-2 infection by ANO6 phospholipid scramblase inhibition. Cell Reports doi: 10.1016/j.celrep.2022.111117 [ACE2- and TMPRSS2-expressing HEK293T stable cell line]
Seenappa, N., et al. (2022). Programming the lymph node immune response with Amphiphile-CpG induces potent cellular and humoral immunity following COVID-19 subunit vaccination in mice and non-human primates. bioRxiv doi: 10.1101/2022.05.19.492649 [COVID-19 Neutralizing Antibody Screening Services]
Minenkova, O., et al. (2022). Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy. Molecular Therapy doi: 10.1016/j.ymthe.2022.02.013 [OMICSLINK™ SARS-CoV-2 Spike alpha, beta, and gamma ORF expression clones]
Ostrov, D.A., et al. (2022).Highly Specific Sigma Receptor Ligands Exhibit Anti-Viral Properties in SARS-CoV-2 Infected Cells. Pathogens doi: 10.3390/pathogens10111514 [OMICSLINK™ ACE2 lentiviral ORF expression clone]
Riccio, A., et al. (2022). Impairment of SARS-CoV-2 spike glycoprotein maturation and fusion activity by nitazoxanide: an effect independent of spike variants emergence. Cellular and Molecular Life Sciences doi: 10.1007/s00018-022-04246-w [OMICSLINK™ SARS-CoV-2 Spike alpha, beta, and gamma ORF expression clones]
Grodzki, M., et al. (2022). Genome-scale CRISPR screens identify host factors that promote human coronavirus infection. Genome Medicine doi: 10.1186/s13073-022-01013-1 [ACE2-expressing HEK293T stable cell line]
Ariumi, Y. (2022). Host Cellular RNA Helicases Regulate SARS-CoV-2 Infection. Journal of Virology doi: 10.1128/jvi.00002 [ACE2-expressing HEK293T stable cell line]
He, C-L., et al. (2022). Identification of bis-benzylisoquinoline alkaloids as SARS-CoV-2 entry inhibitors from a library of natural products in vitro. bioRxiv doi: 10.1101/2020.12.13.420406 [OMICSLINK™ ACE2, DPP4 ORF expression clones]
Kasopefoluwa, Y., et al. (2022). Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera. mBio doi: 10.1128/mBio.02492 [OMICSLINK™ ACE2, TMPRSS2 lentiviral ORF expression clones]
Hu, J., et al. (2022). Reduced neutralization of SARS-CoV-2 B.1.617 variant by convalescent and vaccinated sera. Genes & Diseases doi: 10.1016/j.gendis.2021.11.007 [OMICSLINK™ ACE2 ORF expression clone]
Pivniouk, V., et al. (2022). The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression. Journal of Allergy and Clinical Immunology doi: 10.1016/j.jaci.2021.11.019 [ACE2-expressing HEK293T stable cell line]
Capcha, J.M.C., et al. (2022). Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol. Frontiers in Cardiovascular Medicine doi: 10.3389/fcvm.2020.618651 [OMICSLINK™ ACE2, TMPRSS2, Furin lentiviral ORF expression clones]
Travis, B.J., et al. (2022). Significance of chlorine-dioxide-based oral rinses in preventing SARS-CoV-2 cell entry. Oral Diseases doi: 10.1111/odi.14319 [Lentifect™ SARS-CoV2 Spike-pseudotyped Lentiviral particles; ACE2-expressing HEK293T stable cell line ]

2021

Hashizume, M., et al. (2021). Population-Specific ACE2 Single-Nucleotide Polymorphisms Have Limited Impact on SARS-CoV-2 Infectivity In Vitro. Viruses doi: 10.3390/v13010067 [ACE2-expressing HEK293T stable cell line]
Oguntuyo, K.Y., et al. (2021). Quantifying Absolute Neutralization Titers against SARS-CoV-2 by a Standardized Virus Neutralization Assay Allows for Cross-Cohort Comparisons of COVID-19 Sera. mBio doi: 0.1128/mBio.02492-20 [OMICSLINK™ ACE2, TMPRSS2 lentiviral ORF expression clones]
Tito, A., et al. (2021). Pomegranate Peel Extract as an Inhibitor of SARS-CoV-2 Spike Binding to Human ACE2 Receptor (in vitro): A Promising Source of Novel Antiviral Drugs. Frontiers in Chemistry doi: 10.3389/fchem.2021.638187 [SARS-CoV-2 Spike-pseudotyped lentiviral particles]
Ao, Z., et al .(2021). Identification and evaluation of the inhibitory effect of Prunella vulgaris extract on SARS-coronavirus 2 virus entry. PLOS ONE doi: 10.1371/journal.pone.0251649 [ACE2-expressing HEK293T stable cell line]
Paidi, R.K., et al. (2021). Eugenol, a Component of Holy Basil (Tulsi) and Common Spice Clove, Inhibits the Interaction Between SARS-CoV-2 Spike S1 and ACE2 to Induce Therapeutic Responses. Journal of Neuroimmune Pharmacology doi: 10.1007/s11481-021-10028-1 [SARS-CoV-2 Spike-pseudotyped lentiviral particles; ACE2-expressing HEK293T stable cell line]
Basu, A., et al. (2021). A structurally conserved RNA element within SARS-CoV-2 ORF1a RNA and S mRNA regulates translation in response to viral S protein-induced signaling in human lung cells. Journal of Virology doi: 10.1128/JVI.01678-21 [SARS-CoV-2 Spike-pseudotyped lentiviral particles]
Paidi, R.K., et al. (2022). Selective Inhibition of the Interaction between SARS-CoV-2 Spike S1 and ACE2 by SPIDAR Peptide Induces Anti-Inflammatory Therapeutic Responses. Journal of Immunology doi: 10.4049/jimmunol.2100144 [ACE2-expressing HEK293T stable cell line; Lentifect™ SARS-CoV2 Spike-pseudotyped Lentiviral particles]

2020

Reznikov, L.R., et al. (2020). Identification of antiviral antihistamines for COVID-19 repurposing. Biochemical and Biophysical Research Communications doi: 10.1016/j.bbrc.2020.11.095 [ACE2-expressing HEK293T stable cell line]